Scientists have produced pigs that can resist one of the world’s most costly animal diseases, by changing their genetic code. And the animals show no signs that the change in their DNA has had any other impact on their health or wellbeing — yet.
To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
Researchers from the Mayo Clinic recommends genetic testing for all pancreatic cancer patients as the new standard of care, after finding six genetic mutations in patients with no family history of the disease.
When it comes to understanding what makes people tick—and get sick—medical science has long assumed that the bigger the sample of human subjects, the better. New research suggests this big data approach may be wildly off the mark.
The Wellcome Sanger Institute has provided evidence and made recommendations for an inquiry by the UK Parliament Science and Technology Committee into an immigration system that works for science and innovation, following Brexit.
Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced disease. This subset of tumours was responsive to immunotherapy treatment.
DNA is often referred to as the blueprint of life, however, scientists have for the first time discovered a microbe that uses two different translations of the DNA code at random.
A large study has found that knowing your genetic risk for various diseases makes people switch to healthier lifestyles, and stick to them.